India-based global pharmaceutical company Dr Reddy's Laboratories has received approval from the FDA for trandolapril tablets, according to Reuters.
Subscribe to our email newsletter
The drug is a generic version of Abbott Laboratories’ Mavik tablets and is indicated for the treatment of hypertension.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.